Type 2 Diabetes Mellitus and Protein-Tyrosine Phosphatase 1B1

  • Zou W
N/ACitations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Diabetes is one of the common metabolic diseases, mainly divided into two types, type 1 diabetes mellitus and type 2 diabetes mellitus. Insulin resistance is the main performance of type 2 diabetes mellitus which are relative to some gene mutation, genetics, obesity and so on. Protein-tyrosine phosphatase 1B (PTP1B) plays an important role as a negative regulator in insulin signaling pathways that are implicated in metabolic diseases such as obesity and type 2 diabetes. Many evidences from clinical and basical research show that the high expression of PTP1B induces insulin resistance and PTP1B is an effective target for the treatment of type 2 diabetes mellitus. In this review, we briefly introduce composition of PTP1B, and then examine the role of PTP1B in insulin signaling of type 2 diabets mellitus. Finally, we highlight the recent research progress of PTP1B inhibitors used in therapy of type 2 diabetes mellitus.

Cite

CITATION STYLE

APA

Zou, W. (2016). Type 2 Diabetes Mellitus and Protein-Tyrosine Phosphatase 1B1. Journal of Diabetes, Metabolic Disorders & Control, 3(8). https://doi.org/10.15406/jdmdc.2016.03.00096

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free